Results 71 to 80 of about 2,381,877 (194)

HER2 Testing in Endometrial Serous Carcinoma.

open access: yesArchives of Pathology & Laboratory Medicine, 2020
CONTEXT.— Endometrial serous carcinoma is an aggressive subtype of endometrial cancer with the highest rate of recurrence and mortality among all histotypes.
N. Buza
semanticscholar   +1 more source

LncRNA TDRG1 enhances tumorigenicity in endometrial carcinoma by binding and targeting VEGF-A protein.

open access: yesBiochimica et Biophysica Acta - Molecular Basis of Disease, 2018
Endometrial carcinoma is one of the most frequently diagnosed cancers in females. Long non-coding RNAs (lncRNAs) have been associated with cancer; its role in endometrial carcinoma is an emerging area of research. In this article, lncRNA TDRG1 expression
Shuo Chen   +6 more
semanticscholar   +1 more source

Control of human endometrial stromal cell motility by PDGF-BB, HB-EGF and trophoblast-secreted factors [PDF]

open access: yes, 2013
Human implantation involves extensive tissue remodeling at the fetal-maternal interface. It is becoming increasingly evident that not only trophoblast, but also decidualizing endometrial stromal cells are inherently motile and invasive, and likely ...
Annemarie Samalecos   +39 more
core   +1 more source

Androgen receptor expression in endometrial carcinoma and its correlation with clinicopathologic features

open access: yesBMC Research Notes, 2018
Objectives Recent evidence suggests a role of androgen receptor expression as a prognostic and therapeutic biomarker in endometrial carcinoma, therefore in the present study we aimed to evaluate the frequency of androgen expression in different subtypes ...
Atif Ali Hashmi   +7 more
doaj   +1 more source

Dedifferentiated endometrial carcinoma arising from serous carcinoma: Diagnostic challenges and recommendations [PDF]

open access: yes, 2023
•Dedifferentiated endometrial carcinoma arising from serous carcinoma (null-type P53). •Differential diagnosis including carcinosarcoma, FIGO grade 3 endometrioid carcinoma.
Saikia, Kasturi   +2 more
core   +1 more source

Diagnostic, prognostic, and predictive importance of neutrophil/lymphocyte ratio (NLR), platelet/lymphocyte ratio (PLR), and CA125 in endometrial hyperplasia and carcinoma

open access: yesIndian Journal of Pathology and Microbiology
Background: Inflammation has an important role in the progression of endometrial carcinoma. Aims: The aim of this study is to find the association between neutrophil/lymphocyte ratio (NLR), platelet/lymphocyte ratio (PLR), and CA125 in endometrial ...
Bharti Kumari   +5 more
doaj   +1 more source

E-cadherin and CD10 expression in atypical hyperplastic and malignant endometrial lesions

open access: yesJournal of the Egyptian National Cancer Institute, 2014
Background: Loss of E-cadherin is a critical step for development and progression of malignant tumors. CD10; a marker of non-neoplastic and neoplastic endometrial stroma, is associated with aggressiveness of many epithelial malignancies.
Ahmed R.H. Ahmed, Eman M.S. Muhammad
doaj   +1 more source

Characteristics of the endometrial carcinoma (EC) samples.

open access: yes, 2014
Characteristics of the endometrial carcinoma (EC) samples.
Binya Liu (517729)   +7 more
core   +1 more source

Loss of PTEN Immunoexpression in Endometrial Carcinoma: A Narrative Review [PDF]

open access: yesJournal of Clinical and Diagnostic Research
Endometrial carcinoma is one of the important health issues addressed globally. Therefore, understanding the molecular pathogenesis of endometrial carcinoma for the purpose of prognostic and predictive markers remains in the centre of research.
Garima Chandrakar, Arvind Bhake
doaj   +1 more source

Expression Analysis of FANCD2 in Endometrial Carcinoma [PDF]

open access: yes
Li Zhang,1 Juan Chang,2 Xiuwei Wu2 1Department of Obstetrics and Gynecology, Taihe Hospital, Hubei University of Medicine, Shiyan, Hubei, 442000, People’s Republic of China; 2Department of Hematology, Taihe Hospital, Hubei University of Medicine, Shiyan,
Zhang L, Chang J, Wu X
core  

Home - About - Disclaimer - Privacy